Plasma immunoreactive proopiolipomelanocortin-derived peptides in patients with primary hyperaldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism.

MLA

Güllner, H. G., et al. “Plasma Immunoreactive Proopiolipomelanocortin-Derived Peptides in Patients with Primary Hyperaldosteronism, Idiopathic Hyperaldosteronism with Bilateral Adrenal Hyperplasia, and Dexamethasone-Suppressible Hyperaldosteronism.” The Journal of Clinical Endocrinology and Metabolism, vol. 56, no. 4, Apr. 1983, pp. 853–55. EBSCOhost, https://doi.org/10.1210/jcem-56-4-853.

APA

Güllner, H. G., Nicholson, W. E., Gill, J. R., Jr, & Orth, D. N. (1983). Plasma immunoreactive proopiolipomelanocortin-derived peptides in patients with primary hyperaldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism. The Journal of Clinical Endocrinology and Metabolism, 56(4), 853–855. https://doi.org/10.1210/jcem-56-4-853

Chicago

Güllner, H G, W E Nicholson, J R Gill Jr, and D N Orth. 1983. “Plasma Immunoreactive Proopiolipomelanocortin-Derived Peptides in Patients with Primary Hyperaldosteronism, Idiopathic Hyperaldosteronism with Bilateral Adrenal Hyperplasia, and Dexamethasone-Suppressible Hyperaldosteronism.” The Journal of Clinical Endocrinology and Metabolism 56 (4): 853–55. doi:10.1210/jcem-56-4-853.